Global Triptorelin Market Analysis , Region, opportunities, Forecast period (2021-2028).



 Triptorelin is a drug that acts as an agonist analog of gonadotropin-releasing hormone, reversibly suppressing the expression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is offered under the brand names Decapeptyl and Gonapeptyl, among others.

Triptorelin is a peptide injection formulation that was originally developed to treat advanced metastatic prostate cancer. Treatment of uterine fibroids (a benign tumor of muscular tissues in the uterus), endometriosis before surgery, early-onset puberty and female infertility are among the various indications that have emerged since then (in vitro fertilization).

As part of androgen deprivation therapy, triptorelin is used to treat prostate cancer.

Hormone replacement therapy to reduce testosterone or estrogen levels in transgender people is another prevalent usage in the United Kingdom. Other medicines used by trans persons to inhibit sex hormones include spironolactone and cyproterone acetate, although these drugs have a completely different mechanism of action. It can also be taken as a puberty blocker

The Triptorelin Market is growing due to increased research & development in triptorelin for usage in various therapeutic indications by private producers and research institutions. Several clinical trials are now underway to see if triptorelin may be used to treat breast cancer and the Human Immunodeficiency Virus (HIV). Triptorelin's widespread use in prostate cancer, salivary gland cancer, and central precious puberty is also projected to drive market expansion throughout the foreseeable period. Furthermore, triptorelin's efficacy and safety in the reduction of gonadotropin secretion in prostate cancer and precocious puberty are expanding its market adoption.

To maintain their market position, triptorelin product producers are updating their product portfolios by employing inorganic expansion tactics. Debiopharm and Ipsen, for example, announced the renewal of their Decapeptyl deal in June 2019, which extends and enhances their strategic cooperation for Decapeptyl development, manufacturing, and distribution across Europe, as well as certain Asian and African regions, until 2034.

Teva Pharmaceutical Industries Ltd. also completed the acquisition of Allergan's generics business, Actavis Generics, in August 2016. This strategic merger brings together two top generic pharmaceutical companies with complementary strengths in research and development (R&D), product pipeline and portfolio, operational skills, and regional footprint capabilities.

The Triptorelin market key players are working to diversify their product range across various geographies. For example, in January 2019, Debiopharm Group and Allergan announced an agreement to begin a transition process for Trelstar (Triptorelin pamoate), which will result in new licensees taking over Trelstar commercialization in the United States and Canada and the termination of Allergan's license.

The COVID-19 has an impact on the global economy since it directly affects production and demand disrupts supply chains and marketplaces and has a financial impact on enterprises and financial markets. The global triptorelin market has slowed since the COVID-19 epidemic, as stakeholders look for better ways to diagnose and treat COV patients.

The triptorelin market is divided into three types of drugs: triptorelin pamoate, triptorelin acetate, and triptorelin embonate. Triptorelin pamoate is predicted to grow at the quickest rate among them during the forecast period. Debiopharm has developed three triptorelin pamoate sustained-release formulations (one, three, and six months).

Decapeptyl (Ipsen), Diphereline, and Gonapeptyl are just a few of the brand names for triptorelin (Ferring Pharmaceuticals). Watson Pharmaceuticals sells it as Trelstar, while Arbor Pharmaceuticals sells it as Triptodur (an extended-release 6-month depot injection). Triptorelin is sold in Iran under the brand name 

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more